Moomoo AI 已提取核心信息
Cardio Diagnostics Holdings, Inc. has submitted a delaying amendment to the U.S. Securities and Exchange Commission (SEC) for its Registration Statement on Form S-3, originally filed on January 26, 2024. The amendment, dated January 29, 2024, is intended to delay the effective date of the registration statement. The company has included the delaying amendment language as required by Rule 473 of the Securities Act of 1933. This language indicates that the registration statement's effective date will be postponed until a further amendment is filed to specify its effectiveness in accordance with section 8(a) of the Securities Act, or until the SEC determines an effective date under the same section. Cardio Diagnostics Holdings has provided contact information for Rupert Russell for any questions or comments from the SEC staff.
Cardio Diagnostics Holdings, Inc. has submitted a delaying amendment to the U.S. Securities and Exchange Commission (SEC) for its Registration Statement on Form S-3, originally filed on January 26, 2024. The amendment, dated January 29, 2024, is intended to delay the effective date of the registration statement. The company has included the delaying amendment language as required by Rule 473 of the Securities Act of 1933. This language indicates that the registration statement's effective date will be postponed until a further amendment is filed to specify its effectiveness in accordance with section 8(a) of the Securities Act, or until the SEC determines an effective date under the same section. Cardio Diagnostics Holdings has provided contact information for Rupert Russell for any questions or comments from the SEC staff.
Cardio Diagnostics Holdings, Inc.已向美国证券交易委员会（SEC）提交了最初于2024年1月26日提交的S-3表格注册声明的延迟修正案。该修正案于2024年1月29日生效，旨在推迟注册声明的生效日期。该公司已按照1933年《证券法》第473条的要求纳入了延迟修正案的措辞。这种措辞表明，注册声明的生效日期将推迟到根据《证券法》第8（a）条提交进一步的修正案以说明其有效性之后，或者直到美国证券交易委员会根据同一条款确定生效日期。对于美国证券交易委员会工作人员提出的任何问题或评论，Cardio Diagnostics Holdings已提供了鲁珀特·罗素的联系信息。
Cardio Diagnostics Holdings, Inc.已向美国证券交易委员会（SEC）提交了最初于2024年1月26日提交的S-3表格注册声明的延迟修正案。该修正案于2024年1月29日生效，旨在推迟注册声明的生效日期。该公司已按照1933年《证券法》第473条的要求纳入了延迟修正案的措辞。这种措辞表明，注册声明的生效日期将推迟到根据《证券法》第8（a）条提交进一步的修正案以说明其有效性之后，或者直到美国证券交易委员会根据同一条款确定生效日期。对于美国证券交易委员会工作人员提出的任何问题或评论，Cardio Diagnostics Holdings已提供了鲁珀特·罗素的联系信息。
有用
没用